 |
|
Changes in sex steroids associated with menopause
October 01, 2008Objective and subjective measures show that postmenopausal women slept longer than premenopausal women but felt less satisfied with the quality of sleep
Westchester, Ill.- A study in the Oct. 1 issue of the journal Sleep shows that the increased rate of follicle stimulating hormone (FSH) change that occurs during menopause is associated with increased objective sleep duration but poor subjective sleep quality.
Findings from the sleep profiles created for the study's 365 participants indicate that postmenopausal women had deeper sleep and longer total sleep time than premenopausal women. The faster rate of change in FSH was associated with slow wave sleep and sleep duration, indicating that as women transitioned more rapidly from an endocrine perspective, they slept longer. Simultaneously, however, FSH change was associated with poorer self-reported sleep quality.
"We found that it was not the level of the FSH that was predictive of sleep, bout how quickly these menopause transition changes - FSH changes - occurred when hormones were measured over a seven-year period," said principal investigator MaryFran Sowers, PhD, professor of epidemiology at the University of Michigan.
Women who are nearing the end of the menopause cycle, as reflected by the decreasing ratio of estradiol to testosterone, have more sleep consolidation, or uninterrupted sleep, than women who are in the early stages of menopause. Estradiol is a sex hormone that has a critical impact on reproductive and sexual functioning.
"Sleep characteristics and quality were not affected by the level of estradiol or its rate of change. We believe that this is because estradoil levels do not decline gradually in most women (as is frequently and erroneously believed), and most of the fall in estradiol levels occurs within a year or two of the final menstruation period," Sowers said.
Menopause is a four-to-10 year multifaceted process occurring in women at mid-life and is associated with numerous factors that might trigger or exacerbate sleep disturbances.
Findings also show that women with higher testosterone (at levels that are still considered to be normal), or who are close to the completion of the transition process, have less sleep discontinuity, or waking after the onset of sleep.
Sixty-seven percent of women included in the sleep study were classified as premenopausal (no change in menstrual bleeding regularity) and early perimenopasual (menses in the preceding three months with an increase in bleeding irregularity), 21 percent were identified as late perimenopasual (menses in the previous 12 months, but not in the previous three months), and 11 percent were classified as postmenopausal (12 months of amenorrhea). The median age was 52 years and median body mass index (BMI) was 28 kg. Women slept for a median of nearly six-and-a-half hours per night of the study with a median 40 minutes of wakefulness following sleep onset.
The cross-sectional sleep substudy utilized information obtained from the Study of Women's Health Across the Nation (SWAN) in addition to data collected for a sleep-study profile from 365 Caucasian, African-American and Chinese women. Data were gathered through objective in-home polysomnography and subjective measures such as the Pittsburgh Sleep Quality Index.
SWAN is a multiethnic, community-based, multisite cohort study of the menopausal transition. The study included a comprehensive analysis of sleep (a single sleep study that lasted for three nights) nested within an ongoing longitudinal study and was conducted at four of the seven SWAN clinical sites during 2003-2005.
The sleep study for the sleep profile began within seven days of the beginning of the follicular phase of the menstrual cycle in premenopausal women who were still menstruating. Polysomnography was conducted in the homes of participants.
Women using hormone therapy were excluded from the study, because it would confound the hormone results. Some studies provide evidence that HT can improve some, but not all , aspects of sleep quality in postmenopausal women, and it has been proposed for therapeutic use in menopausal women with sleep related breathing disorders.
The researchers suggest that clinicians whose patients include women with rapid transitions may consider interventions (therapeutic and/or lifestyle changes) that address menopausal symptoms, if any, rather than being limited to interventions that target only sleep characteristics.
American Academy of Sleep Medicine
"We found that it was not the level of the FSH that was predictive of sleep, bout how quickly these menopause transition changes - FSH changes - occurred when hormones were measured over a seven-year period," said principal investigator MaryFran Sowers, PhD, professor of epidemiology at the University of Michigan.
Women who are nearing the end of the menopause cycle, as reflected by the decreasing ratio of estradiol to testosterone, have more sleep consolidation, or uninterrupted sleep, than women who are in the early stages of menopause. Estradiol is a sex hormone that has a critical impact on reproductive and sexual functioning.
"Sleep characteristics and quality were not affected by the level of estradiol or its rate of change. We believe that this is because estradoil levels do not decline gradually in most women (as is frequently and erroneously believed), and most of the fall in estradiol levels occurs within a year or two of the final menstruation period," Sowers said.
Menopause is a four-to-10 year multifaceted process occurring in women at mid-life and is associated with numerous factors that might trigger or exacerbate sleep disturbances.
Findings also show that women with higher testosterone (at levels that are still considered to be normal), or who are close to the completion of the transition process, have less sleep discontinuity, or waking after the onset of sleep.
Sixty-seven percent of women included in the sleep study were classified as premenopausal (no change in menstrual bleeding regularity) and early perimenopasual (menses in the preceding three months with an increase in bleeding irregularity), 21 percent were identified as late perimenopasual (menses in the previous 12 months, but not in the previous three months), and 11 percent were classified as postmenopausal (12 months of amenorrhea). The median age was 52 years and median body mass index (BMI) was 28 kg. Women slept for a median of nearly six-and-a-half hours per night of the study with a median 40 minutes of wakefulness following sleep onset.
The cross-sectional sleep substudy utilized information obtained from the Study of Women's Health Across the Nation (SWAN) in addition to data collected for a sleep-study profile from 365 Caucasian, African-American and Chinese women. Data were gathered through objective in-home polysomnography and subjective measures such as the Pittsburgh Sleep Quality Index.
SWAN is a multiethnic, community-based, multisite cohort study of the menopausal transition. The study included a comprehensive analysis of sleep (a single sleep study that lasted for three nights) nested within an ongoing longitudinal study and was conducted at four of the seven SWAN clinical sites during 2003-2005.
The sleep study for the sleep profile began within seven days of the beginning of the follicular phase of the menstrual cycle in premenopausal women who were still menstruating. Polysomnography was conducted in the homes of participants.
Women using hormone therapy were excluded from the study, because it would confound the hormone results. Some studies provide evidence that HT can improve some, but not all , aspects of sleep quality in postmenopausal women, and it has been proposed for therapeutic use in menopausal women with sleep related breathing disorders.
The researchers suggest that clinicians whose patients include women with rapid transitions may consider interventions (therapeutic and/or lifestyle changes) that address menopausal symptoms, if any, rather than being limited to interventions that target only sleep characteristics.
American Academy of Sleep Medicine
Menopause Current Events and Menopause News RSSMayo researchers offer new insight into effectiveness of procedure to stop heavy menstrual bleeding
Experts estimate that 20 percent of women experience excessive or prolonged menstrual bleeding at some time during their lives, particularly as they approach menopause.
Study links obesity to elevated risk of ovarian cancer
A new epidemiological study has found that among women who have never used menopausal hormone therapy, obese women are at an increased risk of developing ovarian cancer compared with women of normal weight.
Estrogen therapy could be dangerous for women with existing heart risk
Hormone therapy could accentuate certain pre-existing heart disease risk factors and a heart health evaluation should become the norm when considering estrogen replacement, new research suggests.
M.I.N.D. Institute researchers call for fragile X testing throughout the lifespan
Writing in this week's Journal of the American Medical Association, UC Davis M.I.N.D. Institute researchers urge physicians to test for mutations of the fragile X gene in patients of all ages.
Why women should eat less, move more and consider wearing transdermal HRT patches during menopause
Weight and appetite experts from around the world met at a conference in Bangkok earlier this year to discuss sex differences in obesity. One line of discussion looked at factors leading to women's weight gain during menopause, and how it might be avoided.
Ultrasound waves aid in rapid treatment of DVT
The use of ultrasound waves for deep vein thrombosis (DVT) may help dissolve blood clots in less time than using clot-busting drugs alone, according to researchers at Emory University.
New hormone data can predict menopause within a year
For many women, including the growing number who choose later-in-life pregnancy, predicting their biological clock's relation to the timing of their menopause and infertility is critically important.
Birth control has long-term effect on hormone exposure
Researchers at Wake Forest University School of Medicine may be one step closer to understanding why past oral contraceptive use dramatically lowers the risk of ovarian and uterine cancers later in life.
Herbal Menopause Therapy a Good Fit for Breast Cancer Patients?
When it comes to understanding the effectiveness and safety of using herbal therapies with other drugs, much is unknown. Now, a University of Missouri researcher will study how black cohosh - an herbal supplement often used to relieve hot flashes in menopausal women - interacts with tamoxifen, a common drug used to treat breast cancer.
The dietary supplement genistein can undermine breast cancer treatment
Women taking aromatase inhibitors to treat breast cancer or prevent its recurrence should think twice before also taking a soy-based dietary supplement, researchers report.
More Menopause Current Events and Menopause News Articles
 | The Wisdom of Menopause: Creating Physical and Emotional Health and Healing During the Change, 2nd Edition by Christiane Northrup Through her bestselling books, groundbreaking PBS specials, and up-to-the-minute clinical knowledge, Dr. Christiane Northrup has earned a place as one of America’s most trusted medical advisors.In The Wisdom of Menopause, she once again challenges convention with this inspiring look at one of the most commonly misunderstood female health issues. The “change” is not simply a collection of... |
 | What Your Doctor May Not Tell You About Menopause (TM): The Breakthrough Book on Natural Hormone Balance by John R. Lee, Virginia Hopkins The classic bestseller that has helped nearly a million women discover the answer to menopause is now revised and updated. Hot flashes, night sweats, weight gain, low sex drive, hair loss, fibroids, and osteoporosis-most women will experience these or other hormone- related problems at some point as they age. In clear, easy-to-understand language, an internationally recognized expert explains the... |
 | The Secret Pleasures of Menopause by Christiane Northrup The Secret Pleasures of Menopause is a groundbreaking book that is long overdue! Christiane Northrup, M.D., delivers a breakthrough message that will help millions and millions of perimenopausal and menopausal women just like you understand that at menopause . . . life has just begun! It is the beginning of a very exciting and fulfilling time, full of pleasure beyond your wildest... |
 | The Wisdom of Menopause Journal: Your Guide to Creating Vibrant Health and Happiness in the Second Half of Your Life by Christiane Northrup Menopause is an unparalleled opportunity to turn your life around and create a firm foundation for the most fulfilling, healthy, joy-filled years of your life. The Wisdom of Menopause Journal—a companion to Dr. Christiane Northrup’s newly revised and best-selling book The Wisdom of Menopause—helps you focus on the “me” in menopause. Designed to help you both navigate and document this... |
 | The Menopause Diet by Larrian Gillespie |
 | Is it Hot in Here? Or is it me? The Complete Guide to Menopause by Barbara Kantrowitz, Pat Wingert Kelly For significant milestones, significant books: first, Our Bodies, Ourselves, then What to Expect When You’re Expecting, and now, Is it Hot in Here? Or is it me? The Complete Guide to Menopause. Written with an uncompromising intelligence and wit by two award-winning Newsweek journalists, Is it Hot in Here? Or is it me? is the essential, comprehensive, up-to-the-minute, deeply optimistic book... |
 | Dr. Susan Love's Menopause and Hormone Book: Making Informed Choices by Susan M. Love, Karen Lindsey In the first edition of this important bestselling book, praised by Newsday as “the bible for a whole generation of menopausal women,” renowned physician and pioneering women’s health advocate Dr. Susan Love warned about the potential dangers of the long-term prescription of hormone replacement therapy. Her insightful words of caution have been backed up by the stunning results of the... |
 | The Only Menopause Guide You'll Need (A Johns Hopkins Press Health Book) by Michele C. Moore For women facing decisions about treatment for the symptoms of menopause, the second edition of this landmark work features a new chapter that addresses the latest findings about hormone replacement therapy. Dr. Michele Moore helps patients make informed treatment choices and offers a balanced account of options that range from traditional medical practice to holistic and alternative... |
 | Sex, Lies, and Menopause: The Shocking Truth About Synthetic Hormones and the Benefits of Natural Alternatives by T. S. Wiley, Julie Taguchi, Bent Formby Turning thirty years of medical and cultural wisdom on its head, Sex, Lies, and Menopause challenges both the medical establishment and modern feminists to prove that menopause does not have to be deadly. In this revolutionary work -- a landmark that signals the true beginning of feminist medicine -- a doctor, a philosopher, and a scientist prove that by postponing marriage and motherhood, women... |
 | Our Bodies, Ourselves: Menopause by Boston Women's Health Book Collective, Judy Norsigian FROM THE EDITORS OF THE CLASSIC "BIBLE OF WOMEN'S HEALTH," A TRUSTWORTHY, UP-TO-DATE GUIDE TO HELP EVERY WOMAN NAVIGATE THE MENOPAUSE TRANSITIONFor decades, millions of women have relied on Our Bodies, Ourselves to provide the most comprehensive, honest, and accurate information on women's health. Now, in Our Bodies, Ourselves: Menopause, the editors of the classic guide discuss the transition of... |
| © 2009 BrightSurf.com |